Back

The importance of changes in prognostic markers during the management of HFrEF : reassessment better predicts the outcomes than the initial evaluation.

28 May 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 4 - Chronic Heart Failure – Epidemiology, Prognosis, Outcome Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2019

About the speaker

Photo
Mr Francois Picard

Martignas Sur Jalle (France)

18 More presentations in this session

Presentation thumbnail
Doctor M. Grundtvig (Lillehammer, NO)
Abstract Slides
Presentation thumbnail
Doctor C. Saldarriaga (Medellin, CO)
Abstract
Presentation thumbnail
Doctor S. Galindo (Cali, CO)
Abstract Slides
Presentation thumbnail
Professor J. Skoularigis (Larissa, GR)
Abstract Slides
Presentation thumbnail
Doctor M. Muksinova (Moscow, RU)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Chronic Heart Failure – Epidemiology, Prognosis, Outcome

The Event

Event poster

Heart Failure 2019

28 May 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic importance of changes in 6-min walk test during titration of pharmacotherapy in HFrEF
21 May 2023
thumbnail
Congress Presentation
In-silico mechanistic interpretation of echocardiographic predictors of reverse remodeling after cardiac resynchronization therapy
30 August 2026
thumbnail
Congress Presentation
Comparison of four novel biomarkers alongside NT-proBNP for risk assessment of heart failure or death within 1 year from admission with acute dyspnoea
1 September 2025
thumbnail
Congress Presentation
Analysis of the dynamics and prognostic significance of inflammatory markers in patients with heart failure who underwent acute coronary syndrome and percutaneous coronary intervention
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources